Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model
Crossref DOI link: https://doi.org/10.1007/s00432-017-2564-6
Published Online: 2018-01-11
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Menssen, Hans D.
Harnack, Ulf
Erben, Ulrike
Neri, Dario
Hirsch, Burkhard
Dürkop, Horst
License valid from 2018-01-11